Siemens Fonds Invest GmbH Has $1.49 Million Stock Position in Revvity, Inc. (NYSE:RVTY)

Siemens Fonds Invest GmbH increased its holdings in shares of Revvity, Inc. (NYSE:RVTY - Free Report) by 264.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 13,357 shares of the company's stock after purchasing an additional 9,696 shares during the period. Siemens Fonds Invest GmbH's holdings in Revvity were worth $1,491,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in RVTY. T. Rowe Price Investment Management Inc. increased its stake in Revvity by 16.7% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 20,761,308 shares of the company's stock valued at $2,317,170,000 after acquiring an additional 2,969,326 shares during the period. EdgePoint Investment Group Inc. grew its holdings in shares of Revvity by 51.1% during the 4th quarter. EdgePoint Investment Group Inc. now owns 4,058,231 shares of the company's stock worth $452,939,000 after purchasing an additional 1,372,456 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in shares of Revvity by 17.8% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 7,631,597 shares of the company's stock worth $851,764,000 after purchasing an additional 1,151,821 shares in the last quarter. Norges Bank bought a new stake in shares of Revvity during the fourth quarter valued at approximately $127,801,000. Finally, Invesco Ltd. raised its stake in shares of Revvity by 18.8% in the fourth quarter. Invesco Ltd. now owns 1,740,933 shares of the company's stock valued at $194,306,000 after purchasing an additional 274,923 shares in the last quarter. Institutional investors and hedge funds own 86.65% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on RVTY shares. Barclays lowered their price target on shares of Revvity from $140.00 to $110.00 and set an "overweight" rating on the stock in a report on Thursday, April 10th. Raymond James reissued an "outperform" rating and issued a $120.00 target price (down previously from $145.00) on shares of Revvity in a research note on Tuesday, April 29th. KeyCorp raised their price target on shares of Revvity from $132.00 to $145.00 and gave the stock an "overweight" rating in a research note on Monday, February 3rd. Robert W. Baird cut their price objective on Revvity from $127.00 to $125.00 and set an "outperform" rating for the company in a report on Tuesday, April 29th. Finally, The Goldman Sachs Group lowered their target price on shares of Revvity from $140.00 to $125.00 and set a "buy" rating on the stock in a report on Tuesday, April 29th. Four equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $125.64.

Revvity Price Performance

Shares of RVTY stock traded up $0.44 during trading hours on Thursday, reaching $90.27. 536,019 shares of the company were exchanged, compared to its average volume of 1,130,916. The company has a market cap of $10.64 billion, a price-to-earnings ratio of 40.83, a P/E/G ratio of 3.82 and a beta of 1.02. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03. The stock's fifty day moving average is $97.62 and its two-hundred day moving average is $109.81. Revvity, Inc. has a fifty-two week low of $88.53 and a fifty-two week high of $129.50.

Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings data on Monday, April 28th. The company reported $1.01 earnings per share for the quarter, topping the consensus estimate of $0.96 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. The firm had revenue of $664.76 million during the quarter, compared to analysts' expectations of $662.30 million. During the same period in the previous year, the business posted $0.98 EPS. The company's quarterly revenue was up 2.3% compared to the same quarter last year. Sell-side analysts forecast that Revvity, Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 8th. Shareholders of record on Friday, July 18th will be issued a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, July 18th. This represents a $0.28 annualized dividend and a yield of 0.31%. Revvity's dividend payout ratio is presently 11.91%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.